Architects of 21st Century Cures Act seek input on Cures Act 2.0

Three years after the passage of the 21st Century Cures Act, Reps. Diana DeGette (D-CO) and Fred Upton (R-MI) are starting work on a version 2.0 of the bill with a focus on access to new medicines, digital health and furthering the use of real-world evidence (RWE) by the US Food and Drug Administration (FDA).

Read on raps.org (Regulatory Affairs Professional Society)